Vertex Pharmaceuticals Incorporated (VRTX)
$498.50+2.74%Close
SELLBEAR · day 27
Key stats
Short interest · FINRA settlement 2026-09-30
52-week IV13.9%–78.5%
- Market cap
- $126.5B
- Beta
- 0.32
- P/E (TTM)
- 28.78
- IV-%ile
- 6
- IV ATM
- 20.9%
- Short % float
- 1.78%
- Days to cover
- 4.2
- SI change
- -4.5%
- 1W
- -1.41%
- 1M
- -3.13%
- vs SPY 1W
- -0.43%
- vs SPY 1M
- -5.00%
Industry peers
FMP comparable companies · ranked by market cap
- ALNYSELLAlnylam Pharmaceuticals, Inc.$31.1BRECOVERYQ 28$232.68+0.29%
- BBIOSELLBridgeBio Pharma, Inc.$12.8BRECOVERYQ 18$65.35+2.59%
- BMRNSELLBioMarin Pharmaceutical Inc.$10.6BBEARQ 12$54.80+1.40%
- IONSSELLIonis Pharmaceuticals, Inc.$7.5BCRISISQ 8$45.28+0.76%
- PTCTSELLPTC Therapeutics, Inc.$5.4BCRISISQ 18$64.70-0.42%
- CRSPSELLCRISPR Therapeutics AG$5.1BCRISISQ 20$53.39+0.24%
- BEAMBUYBeam Therapeutics Inc.$2.6BRECOVERYQ 13$25.70-3.19%
- SRPTSELLSarepta Therapeutics, Inc.$1.9BCRISISQ 13$17.85+1.94%
- NTLASELLIntellia Therapeutics, Inc.$1.8BRECOVERYQ 3$13.07-4.03%
- RAREBUYUltragenyx Pharmaceutical Inc.$1.5BRECOVERYQ -6$15.48-0.13%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on VRTX?
- LOPJLB’s latest quantitative signal on Vertex Pharmaceuticals Incorporated (VRTX) is SELL in a BEAR regime. Signals are updated daily.
- What market regime is VRTX in?
- Vertex Pharmaceuticals Incorporated (VRTX) is currently classified in the BEAR HMM market regime on LOPJLB.
- What does Vertex Pharmaceuticals Incorporated (VRTX) do?
- Vertex Pharmaceuticals Incorporated is a leading biotechnology firm primarily focused on the discovery, advancement, and marketing of innovative treatments, particularly for cystic fibrosis (CF). The company offers a range of approved medications for CF patients, including SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO, which target specific mutations within the cystic fibrosis transmembrane conductanc…